Compare MYSZ & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | ACON |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 7.4M |
| IPO Year | 2017 | 2022 |
| Metric | MYSZ | ACON |
|---|---|---|
| Price | $1.84 | $2.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 233.2K | 61.1K |
| Earning Date | 04-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.40 | ★ 99.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,000.00 | $75,730.00 |
| Revenue This Year | $41.64 | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 125.40 | 65.62 |
| 52 Week Low | $0.33 | $1.95 |
| 52 Week High | $4.28 | $12.03 |
| Indicator | MYSZ | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 55.65 |
| Support Level | $0.47 | $2.33 |
| Resistance Level | $4.28 | $3.54 |
| Average True Range (ATR) | 0.17 | 0.16 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 4.82 | 58.62 |
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.